WELL Health Technologies (TSE:WELL) Releases Earnings Results

WELL Health Technologies (TSE:WELL) released its quarterly earnings data on Thursday. The company reported C$0.06 earnings per share (EPS) for the quarter, FiscalAI reports. WELL Health Technologies had a negative net margin of 0.53% and a negative return on equity of 0.87%. The firm had revenue of C$368.26 million for the quarter.

Here are the key takeaways from WELL Health Technologies’ conference call:

• Q1 results were strong with revenue of CAD 368.3M (+25% YoY), Adjusted EBITDA of CAD 43.1M (+56%), and adjusted net income of CAD 15.5M (doubled YoY), signaling robust core performance.
• Canadian clinics momentum — the network grew to 253 clinics with 1.3M Canadian patient visits (+31% YoY), is on track to exceed CAD 500M in clinics revenue in 2026, and is targeting ~CAD 800M revenue and >CAD 100M Adjusted EBITDA run-rate within the next 12 months, supported by a CAD 400M senior credit facility and a ~CAD 260M pipeline under LOI.
• Regulatory and procurement tailwinds — federal Bill S?5 and Ontario’s province?wide EMR initiative favor interoperable, sovereign Canadian platforms, positioning WELL’s integrated stack (WELLSTAR, HEALWELL AI, CYBERWELL plus clinics) to compete for large public procurements.
• WHIP, AI and investment phase — WELL is building the WELL Health Intelligence Platform (WHIP) and consolidating CYBERWELL/WELL Research to drive AI?led efficiency and a back?half 2026 cost?optimization program, but Q1 capex rose 88% and adjusted free cash flow fell to CAD 1.6M due to these investments.
• U.S. strategic review and Circle Medical updates — WELL is pursuing strategic alternatives for U.S. assets (WISP, Circle Medical, CRH); Circle recognized ~CAD 12.8M of deferred revenue in Q1, expects minimal remaining deferrals in Q2, and reports a deal?in?principle with U.S. regulators, but final outcomes and timing remain uncertain.

WELL Health Technologies Trading Up 0.7%

Shares of TSE WELL traded up C$0.03 during midday trading on Thursday, hitting C$4.37. 1,803,676 shares of the company traded hands, compared to its average volume of 1,465,645. WELL Health Technologies has a 12-month low of C$3.58 and a 12-month high of C$6.08. The company has a debt-to-equity ratio of 82.33, a quick ratio of 1.02 and a current ratio of 1.03. The stock has a 50-day moving average price of C$4.09 and a 200 day moving average price of C$4.14. The firm has a market cap of C$1.12 billion, a P/E ratio of -145.67, a P/E/G ratio of -1.93 and a beta of 0.93.

Wall Street Analyst Weigh In

Separately, Scotiabank reduced their price target on shares of WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating on the stock in a research report on Wednesday, February 4th. Two analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of C$6.25.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.